Track the LSL Pharma Group Inc. share price and the full management transaction log of the company, a listed issuer based in Canada. Shares are listed on CA CA, under the supervision of SEDI. Operating in the Health Care sector, LSL Pharma Group Inc. has recorded 10 public disclosures. Market capitalisation: €39.9m. The latest transaction was filed on 6 July 2026 (50 - Grant of options). Among the most active insiders: Allard, Guy Paul. The full history is accessible without an account.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,220 of 28,169 companies
13.0
score / 100
Value
13
Quality
14
FCF yld-16%
Earn yld-6.3%
EV/EBITDA36.5x
ROE-11%
Gross mgn18%
Net mgn-9.8%
Debt/EBITDA16.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.